The quest for quality blood banking program in the new millennium the American way Dae Un Kim Safety Issues in Blood & Blood Products Transfusion Pages: 258 - 262
An approach to the diagnosis and treatment of bleeding disorders in infants Thomas C. Abshire Non-malignant Hematologic Disorders in Childhood Pages: 265 - 270
Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children Ann E. WoolfreyMichael A. PulsipherRainer Storb Non-malignant Hematologic Disorders in Childhood Pages: 271 - 277
Current concepts in treatment of childhood acute lymphoblastic leukemia Ching-Hon Pui Treatment of Childhood Malignancy Pages: 279 - 279
Childhood acute lymphoblastic Leukemia: Differences in drug resistance between sub-groups of ALL A. J. P. Veerman Treatment of Childhood Malignancy Pages: 280 - 280
Designer drugs: New directed therapies for cancer Stephen A. Feig Treatment of Childhood Malignancy Pages: 281 - 283
Umbilical cord blood for unrelated bone marrow replacement; Asia Bank and Japan cord blood bank network update Hideo MugishimaTuneo TakahashiHidehiko Saito Treatment of Childhood Malignancy Pages: 284 - 286
Role of the Advanced Practice Nurse in blood and marrow transplantation Joyce L. Neumann Role of Blood and Marrow Nurses in Field of Transplants Pages: 288 - 288
Research within the field of blood and marrow transplantation nursing: How can it contribute to higher quality of care? Monica C. Fliedner Role of Blood and Marrow Nurses in Field of Transplants Pages: 289 - 291
The present state of advanced practice nursing in hematopoietic stem cell transplantation field in Korea Jung Hee Hong Role of Blood and Marrow Nurses in Field of Transplants Pages: 292 - 292
Treatment of polycythemia vera with recombinant interferon Richard T. Silver Current Concepts of the Myeloproliferative Diseases Pages: 294 - 295
The therapy of myelofibrosis: Targeting pathogenesis Ruben A. Mesa Current Concepts of the Myeloproliferative Diseases Pages: 296 - 304
Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV Rosemary E. Gale Current Concepts of the Myeloproliferative Diseases Pages: 305 - 310
What is the standard treatment in essential thrombocythemia Tiziano Barbui Current Concepts of the Myeloproliferative Diseases Pages: 311 - 317
